Transcatheter Academy

Prof Francesco Saia, Prof Giuseppe Tarantini and Prof Tanja Rudolph highlight key takeaways across the discussion 👉 ow.ly/AOmx50ZlA3f Key messages include: • Redo TAVI is not a repeat procedure but a forward-looking strategy requiring planning from the index implant to enable safe future intervention • CT-based assessment is central for accurate sizing, positioning and preserving coronary access and redo feasibility • Across SAPIEN valve sizes and mechanisms of failure, invasive gradients remain consistently low, reinforcing procedural performance in redo TAVI #StructuralHeart #TAVI #AorticStenosis #RedoTAVI #InterventionalCardiology

🔴 Just 48 hours remain until 'Valve for Life: Anatomical, Procedural and Device Considerations for Future Re-Intervention'. Secure your place 🔗 ow.ly/72hz50ZvRrK Join co-chairs Prof Rafal Dworakowski and Prof Tony Walton alongside Prof Andrew Cook, Dr Stephanie Sellers, Prof Kent So and Dr Karl Poon. Hear expert perspectives, explore real-world considerations and submit your questions to the panel live! Don't miss practical insights into how initial valve selection influences durability, coronary access and future procedural options. 👋 See you there! #StructuralHeart #TAVI #ValveInValve #InterventionalCardiology #Cardiology

In this 'SAPIEN Platform in Tall Frame THV' discussion, Prof Giuseppe Tarantini highlight the importance of slow-controlled deployment 👉 ow.ly/Qv1F50ZlyvI In this case-based discussion, achieving optimal THV expansion is the key procedural objective, even in anatomically favourable scenarios where the index THV is positioned below the coronary plane 🫀 While the risk of coronary occlusion may be low, inadequate or non-uniform valve expansion remains a critical concern, potentially impacting leaflet durability, and long-term outcomes. For this reason, deployment technique is essential: excessively rapid inflation may lead to suboptimal frame expansion or loss of control during valve deployment. A slower, controlled inflation over approximately 5–6 seconds facilitates homogeneous pressure distribution, promoting complete valve expansion. This approach supports optimal frame geometry, improved leaflet function, and overall procedural predictability, highlighting that even in “low-risk” anatomy, expansion quality remains a central determining factor of procedural success. #StructuralHeart #TAVI #AorticStenosis #RedoTAVI #InterventionalCardiology

Prof Tanja Rudolph highlight procedural planning in a high-risk anatomical setting in this 'SAPIEN Platform in Short Frame THV' discussion 👉 ow.ly/aTeo50Zlysw In this clinical case, a small aortic root combined with CT-derived measurements suggestive of elevated risk at the level of the right coronary artery (RCA) prompted a strategy focused on coronary protection. A protective strategy was implemented with coronary wiring and positioning of an undeployed stent in the RCA prior to valve implantation 🫀 Pre-dilatation was performed due to the presence of a severely stenotic index THV. Following valve implantation, the coronary stent was deployed, confirming preserved RCA patency and the absence of coronary obstruction. #StructuralHeart #TAVI #AorticStenosis #RedoTAVI #InterventionalCardiology

Dr Radoslaw Parma demonstrate key steps in Redo TAVI planning and implantation in this clip from 'SAPIEN Valve in Tall Frame' 👉 ow.ly/6bmu50Zlyl4 In this clinical case a tailored pre- and peri-procedural strategy was adopted to optimize THV-in-THV implantation. Pre-dilatation with a 26 mm Atlas Gold balloon was performed to reduce leaflet resistance from the index valve and facilitate expansion, creating adequate space for the second THV 🫀 A 26 mm SAPIEN 3 Ultra Resilia valve was then positioned and deployed with a relatively higher implant depth, aligned to the patient’s native anatomy and procedural objectives, including optimization of hemodynamic and potential durability. In this specific case, prolonged balloon inflation was used to allow controlled and gradual frame expansion. Concurrent contrast injection during deployment supported real-time assessment of the sealing zone and final valve apposition. #StructuralHeart #TAVI #AorticStenosis #RedoTAVI #InterventionalCardiology

Explore the Structural Heart Case Club UK&I platform, bringing together 10 on-demand episodes featuring expert discussion, real-world cases and peer-to-peer learning from 40 leading structural heart specialists 👉 ow.ly/zoUG50ZzPtR Access practical insights across the full spectrum of structural heart intervention, including: • TAVI • Mitral TEER and tricuspid TEER • Left atrial appendage occlusion (LAAO) • Surgical aortic valve replacement (SAVR) • Surgical mitral valve replacement (SMVR) • PFO, PVL and PDA closure Discover best practices, procedural strategies and evolving approaches through case-based education from experienced operators across the TAVI Case Club, TEER Case Club, SI Case Club and Cardiac Surgery Case Club series 🫀 Watch the full collection on demand and explore the latest insights shaping structural heart practice. #StructuralHeart #TAVI #TEER #LAAO #Cardiology #InterventionalCardiology

In this 'SAPIEN Valve in Tall Frame' discussion, Dr Luis Nombela demonstrate how important is a slow-controlled SAPIEN valve deployment 👉 ow.ly/XUa250Zlyhg In the case presented, a slow and carefully modulated inflation strategy was adopted to enhance device stability and positioning. During the initial phase of balloon expansion, a degree of upward movement toward the aorta may be observed. This is why a controlled inflation allowed progressive stabilization and fine adjustment throughout deployment. Final positioning, in this particular scenario, was achieved just below the right coronary artery, using coronary landmarks as a reference. The inflow portion of the SAPIEN valve was aligned with the lowest coronary reference point, confirming accurate positioning and stable anchoring. Importantly, this approach reflects a case-specific strategy tailored to the patient’s anatomy and procedural context, rather than a universal deployment rule. #StructuralHeart #TAVI #AorticStenosis #RedoTAVI #InterventionalCardiology

As aortic valve interventions expand into younger and lower-risk populations, the first valve choice can shape every future treatment option 🫀 Register for free for 'Valve for Life: Anatomical, Procedural and Device Considerations for Future Re-Intervention' 🔗 ow.ly/oSLk50ZvRlc Join Prof Rafal Dworakowski, Prof Tony Walton and an international faculty live on Wednesday 2 September to explore how valve design, durability, CT planning and coronary access influence lifetime management and future TAV-in-SAV and TAV-in-TAV procedures. #StructuralHeart #TAVI #ValveInValve #InterventionalCardiology

Prof Giuseppe Tarantini discusses haemodynamic assessment after THV implantation in this clip from 'Foundations of Redo TAVI' 👉 ow.ly/9K2P50ZlyaQ He emphasises that invasive gradient measurement is essential, as it consistently shows significantly lower and more accurate values compared with echo 🫀 #StructuralHeart #TAVI #RedoTAVI #AorticStenosis #InterventionalCardiology

Prof Rajesh Kharbanda explains how intentional optimised TAVI team workflows improve efficiency and cath lab performance📈 'Optimising Cath Lab Management to Scale TAVI' is now available on demand for full expert insights 🔗 ow.ly/sxmH50Zrmjh Learn how applying lessons from high-volume centres, structured pre-planning, and team coordination can increase throughput without compromising patient safety and consistency. 🎥 Watch now for practical strategies to deliver reliable, high-quality TAVI workflows in real-world cath labs. #Cardiology #TAVI #CathLab #WorkflowEfficiency #InterventionalCardiology

In this clip from 'Foundations of Redo TAVI', Prof Giuseppe Tarantini emphasizes the critical role of timing in the context of redo intervention and lifetime management of patients undergoing TAVI with results from ReTavi Registry 👉 ow.ly/ibjk50Zlt79 While TAVI is increasingly conceptualized within a lifetime management framework, emerging real-world data indicate that bioprosthetic valve dysfunction requiring reintervention may occur earlier than historically anticipated. Observational evidence suggests a median time to reintervention in the range of approximately 5.6 to 7 years, highlighting variability in valve durability across patient subsets. Although early reintervention applies, by now to a minority of patients, identifying those at higher risk, based on clinical profile, anatomical characteristics, and device-related factors, is essential. Proactive planning for this subgroup is a key component of an optimised, individualised long-term TAVI strategy. #StructuralHeart #TAVI #RedoTAVI #AorticStenosis #InterventionalCardiology

Prof Henryk Dreger explores how cath lab workflow optimisation and patient prioritisation can safely scale TAVI 🫀 Catch up on 'Optimising Cath Lab Management to Scale TAVI' on demand for full expert insights 🔗 ow.ly/v4Tc50ZrlN6 Learn shortening length of stay without compromising individual patient outcomes, alongside a minimalist TAVI approach, increases capacity, reduces delays and improves hospital efficiency. 🎥 Watch now to see practical strategies for implementing safe, time-efficient TAVI workflows in high-volume centres. #Cardiology #TAVI #CathLab #WorkflowEfficiency #InterventionalCardiology

In this clip from 'Foundations of Redo TAVI', Dr Francesco Cardaioli emphasizes the crucial role of multimodality imaging, particularly CT, in planning Redo TAVI procedures 👉 ow.ly/u1Ql50Zlt5l A systematic, CT-based assessment is fundamental to procedural planning and risk stratification. This process begins with accurate identification of the index THV, including device type, size, implantation depth, and expansion profile (e.g., underexpansion or eccentricity), which directly influence Redo TAVI feasibility and outcomes. Comprehensive anatomical evaluation then includes key measurements such as coronary ostial height, sinus of Valsalva and sinotubular junction dimensions, as well as valve-to-coronary (VTC) and valve-to-aorta (VTA) distances. In addition, assessment of commissural alignment and anticipated leaflet displacement is critical to predict the likelihood of coronary obstruction. A structured workflow, integrating stepwise analysis of the risk plane, coronary anatomy, spatial relationships (VTC/VTA), and final re-assessment of obstruction risk, enables consistent and reproducible procedural planning. #StructuralHeart #TAVI #RedoTAVI #AorticStenosis #InterventionalCardiology

In this clip from 'Foundations of Redo TAVI', Dr Luca Nai Fovino set down the central role of aortic root anatomy in determining the risk profile of Redo TAVI 👉 ow.ly/beZa50Zlsjy A favourable anatomical scenario is characterized by a “low-risk” configuration, in which the anticipated risk plane (the level of displaced leaflet interaction following Redo TAVI) remains below the coronary ostia. In this setting, even in the presence of complete displacement of the index THV leaflets, coronary flow and sinotubular junction patency are preserved. On the contrary, the risk of coronary obstruction increases significantly when the risk plane lies above the coronary ostia, particularly in the context of a narrow aortic root or limited sinus of valsalva dimensions. Critical parameters include valve-to-coronary (VTC) and valve-to-aorta (VTA) distances: values <2 mm are associated with a markedly higher risk of coronary obstruction during redo TAVI. In such high-risk anatomical scenarios, pre-procedural planning may necessitate the adoption of coronary protection or mitigation strategies, including chimney (snorkel) stenting or leaflet modification techniques to preserve coronary perfusion and procedural safety. #StructuralHeart #TAVI #RedoTAVI #AorticStenosis #InterventionalCardiology

Gain on-demand access to three 'TEER Case Club episodes' available exclusively on the Structural Heart Case Club UK&I platform 👉 ow.ly/b4NC50ZmQtv Gain practical insights into mitral and tricuspid TEER decision-making, procedural strategy and long-term management from leading structural heart experts 🫀 Catch up on: • Experience Matters When Complex Is Easy 🔗 ow.ly/aR3x50ZmQts • Exploring Advanced TEER 🔗 ow.ly/p3F750ZmQtw • TEER Durability and Patient Lifetime Management 🔗 ow.ly/bPh950ZmQtt Across the series, faculty share real-world perspectives on patient selection, imaging collaboration and optimising outcomes in contemporary TEER practice. #StructuralHeart #TEER #MitralRegurgitation #TricuspidRegurgitation #InterventionalCardiology #Cardiology

Join leading valve specialists Dr Azeem Latib, Dr Raj Makkar, Dr Fabian Praz and Prof Philipp Lurz as they discuss how the latest M-TEER evidence is being applied in clinical practice in this CME-accredited webinar. Register here 🔗 ow.ly/YSwS50Zm36O 🗓️ 13 August | 15:00 BST | 10:00 EDT This programme is supported by an unrestricted educational grant from Edwards Lifesciences.

Prof Francesco Saia discusses the impact of the 2025 ESC guidelines for the management of valvular heart disease on treatment pathways in aortic stenosis within the 'Foundations of Redo TAVI' framework 👉 ow.ly/ZSYP50Zlsao TAVI is increasingly endorsed as the preferred treatment strategy in patients ≥70 years of age with low surgical risk and favourable anatomy, reflecting a continued expansion of indications toward younger and low-risk populations 🫀 This paradigm shift underscores the critical importance of long-term device performance, including bioprosthetic valve durability, risk of structural valve degeneration (SVD), and the lifetime management of patients with aortic stenosis. As highlighted by Prof Saia, a “lifetime management” approach is now essential: procedural planning should begin at the index TAVI, incorporating anatomical considerations (e.g., coronary access, sinus of valsalva dimensions, valve sizing, commissural alignment) to preserve future treatment options. In this context, Redo TAVI must be anticipated as a potential downstream strategy, requiring a tailored, forward-looking approach to optimize long-term outcomes and procedural feasibility over time #StructuralHeart #TAVI #AorticStenosis #ValvularHeartDisease #InterventionalCardiology

Explore three 'TAVI Case Club' episodes on the Structural Heart Case Club UK&I platform, available on demand 👉 ow.ly/XCKT50ZhC61 Gain practical insights into evolving TAVI practice, implantation strategy and patient selection in aortic stenosis from 10 leading faculty experts. Catch up on: • Where it Started, How it's Going: Building Experience 🔗 ow.ly/jAmc50ZhC5Y • How to Define and Achieve an Ideal Depth of TAVI Implant 🔗 ow.ly/RHCs50ZhC5Z • Exploring the Boundaries for Treating Aortic Stenosis 🔗 ow.ly/pfHO50ZhC60 Watch now for real-world cases and peer-to-peer discussion from leading structural heart operators across the series 🫀 #StructuralHeart #TAVI #AorticStenosis #InterventionalCardiology #Cardiology

🔴 Registration closes soon for 'Optimising Cath Lab Management to Scale TAVI' with Dr Kristoffer Russell, Prof Henryk Dreger, Prof Rajesh Kharbanda and Mrs Kate Winn. Secure your place before it's too late 👉 ow.ly/stbp50Z7Hyc This focused live webinar explores improving cath lab efficiency and scaling sustainable TAVI practice, including practical strategies on how to: ✔️ Reduce delays ✔️ Improve workflow and scheduling ✔️ Optimise multidisciplinary coordination ✔️ Increase procedural efficiency ✔️ Support sustainable TAVI growth #TAVI #Cardiology #StructuralHeart #InterventionalCardiology #CathLab

Is your cath lab ready for rising TAVI demand? With procedural pressures continuing to grow, optimising workflow and reducing delays are becoming increasingly important across modern TAVI programmes 📈 Secure your place for 'Optimising Cath Lab Management to Scale TAVI' to explore the key challenges affecting cath lab efficiency in real-world clinical settings 👉 ow.ly/czEG50Z7Huk Join Dr Kristoffer Russell, Prof Henryk Dreger, Prof Rajesh Kharbanda and Mrs Kate Winn to explore how high-performing centres are improving efficiency, patient flow and sustainable procedural capacity. 🗓️ Thursday 25 June 2026, 18:00 CET #TAVI #StructuralHeartDisease #CathLab #Cardiology #InterventionalCardiology